Erratum: Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder (Translational Psychiatry (2015) 5 (e636) DOI: 10.1038/tp.2015.134);Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder

Translational Psychiatry

Volumn 5, Issue 9, 2015, Pages

  Mamdani, F ^a   Rollins, B ^a   Morgan, L ^a   Myers, R M ^b   Barchas, J D ^c   Schatzberg, A F ^d   Watson, S J ^e   Akil, H ^e   Potkin, S G ^a   Bunney, W E ^a   Vawter, M P ^a   Sequeira, P A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DYSKERIN; TELOMERIC REPEAT BINDING FACTOR 1;

ADULT; AMYGDALA; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CELL AGING; CONTROLLED STUDY; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; FKBP5 GENE; GAR1 GENE; GENE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; MENTAL STRESS; MIDDLE AGED; NHP2 GENE; NOP10 GENE; NUCLEUS ACCUMBENS; POLYMERASE CHAIN REACTION; POT1 GENE; SCHIZOPHRENIA; SUBSTANTIA NIGRA; TELOMERE HOMEOSTASIS; TELOMERE LENGTH; TERC GENE; TERF2IP GENE; TINF2 GENE; TPP1 GENE; ANALYSIS OF VARIANCE; BRAIN; CADAVER; DISSECTION; GENETIC PROCEDURES; GENETICS; PATHOLOGY; TELOMERE;

ANALYSIS OF VARIANCE; BRAIN; CADAVER; DEPRESSIVE DISORDER, MAJOR; DISSECTION; FEMALE; GENETIC TECHNIQUES; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TELOMERE;

EID: 84994681215     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.164     Document Type: Erratum

References (54)

1. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12: 1133-1138.
2. Von ZT. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.
3. Bar-Or D, Thomas GW, Rael LT, Lau EP, Winkler JV. Asp-Ala-His-Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening. Biochem Biophys Res Commun 2001; 282: 356-360.
4. Wolkowitz OM, Epel ES, Reus VI, Mellon SH. Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 2010; 27: 327-338.
5. Choi J, Fauce SR, Effros RB. Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav Immun 2008; 22: 600-605.
6. Kao HT, Cawthon RM, Delisi LE, Bertisch HC, Ji F, Gordon D et al. Rapid telomere erosion in schizophrenia. Mol Psychiatry 2008; 13: 118-119.
7. Lung FW, Chen NC, Shu BC. Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr Genet 2007; 17: 195-199.
8. Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006; 60: 432-435.
9. Zhang D, Cheng L, Craig DW, Redman M, Liu C. Cerebellar telomere length and psychiatric disorders. Behav Genet 2010; 40: 250-254.
10. Teyssier JR, Ragot S, Donzel A, Chauvet-Gelinier JC. [Telomeres in the brain cortex of depressive patients]. Encephale 2010; 36: 491-494.
11. Szebeni A, Szebeni K, DiPeri T, Chandley MJ, Crawford JD, Stockmeier CA et al. Shortened telomere length in white matter oligodendrocytes in major depression: potential role of oxidative stress. Int J Neuropsychopharmacol 2014; 17: 1579-1589.
12. Codd V, Mangino M, van der Harst P, Braund PS, Kaiser M, Beveridge AJ et al. Common variants near TERC are associated with mean telomere length. Nat Genet 2010; 42: 197-199.
13. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999; 402: 551-555.
14. Njajou OT, Blackburn EH, Pawlikowska L, Mangino M, Damcott CM, Kwok PY et al. A common variant in the telomerase RNA component is associated with short telomere length. PLoS One 2010; 5: e13048.
15. de LT. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-2110.
16. Frenck RW Jr, Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998; 95: 5607-5610.
17. Nakamura K, Takubo K, Izumiyama-Shimomura N, Sawabe M, Arai T, Kishimoto H et al. Telomeric DNA length in cerebral gray and white matter is associated with longevity in individuals aged 70 years or older. Exp Gerontol 2007; 42: 944-950.
18. Kelly TM, Mann JJ. Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand 1996; 94: 337-343.
19. Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ et al. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 2003; 160: 657-666.
20. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653-15658.
21. Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 2004; 101: 15506-15511.
22. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr. et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006; 63: 35-48.
23. Sequeira A, Klempan T, Canetti L, ffrench-Mullen J, Benkelfat C, Rouleau GA et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007; 12: 640-655.
24. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009; 4: e6585.
25. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One 2012; 7: e35367.
26. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
27. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26: 317-325.
28. Reis PP, Waldron L, Goswami RS, Xu W, Xuan Y, Perez-Ordonez B et al. mRNA transcript quantification in archival samples using multiplexed, colorcoded probes. BMC Biotechnol 2011; 11: 46.
29. Muller KE, Barton CN, Benignus VA. Recommendations for appropriate statistical practice in toxicologic experiments. Neurotoxicology 1984; 5: 113-125.
30. Muller KE, Benignus VA. Increasing scientific power with statistical power. Neurotoxicol Teratol 1992; 14: 211-219.
31. Muller KE, Lavange LM, Ramey SL, Ramey CT. Power calculations for general linear multivariate models including repeated measures applications. J Am Stat Assoc 1992; 87: 1209-1226.
32. Hudson G, Faini D, Stutt A, Eccles M, Robinson L, Burn DJ et al. No evidence of substantia nigra telomere shortening in Parkinson's disease. Neurobiol Aging 2011; 32: 2107-5.
33. Wei Y, Backlund L, Wegener G, Mathe AA, Lavebratt C. Telomerase dysregulation in the hippocampus of a rat model of depression. Normalization by lithium. Int J Neuropsychopharmacol 2015; 18: pyv002.
34. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J Neurosci 1992; 12: 3628-3641.
35. McEwen BS. Brain on stress: how the social environment gets under the skin. Proc Natl Acad Sci USA 2012; 109: 17180-17185.
36. Holstege H, Pfeiffer W, Sie D, Hulsman M, Nicholas TJ, Lee CC et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res 2014; 24: 733-742.
37. Entringer S, Epel ES, Kumsta R, Lin J, Hellhammer DH, Blackburn EH et al. Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proc Natl Acad Sci USA 2011; 108: e513-e518.
38. Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006; 16: 239-249.
39. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313-1317.
40. Jacobs EG, Epel ES, Lin J, Blackburn EH, Rasgon NL. Relationship between leukocyte telomere length, telomerase activity, and hippocampal volume in early aging. JAMA Neurol 2014; 71: 921-923.
41. Meyer RC, Giddens MM, Schaefer SA, Hall RA. GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci USA 2013; 110: 9529-9534.
42. Tomita H, Ziegler ME, Kim HB, Evans SJ, Choudary PV, Li JZ et al. G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 2013; 4: 297.
43. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006; 11: 615, 663-679.
44. Polvani S, Tarocchi M, Galli A. PPARgamma and oxidative stress: con(beta) catenating NRF2 and FOXO. PPAR Res 2012; 2012: 641087.
45. Schnegg CI, Robbins ME. Neuroprotective mechanisms of ppardelta: modulation of oxidative stress and inflammatory processes. PPAR Res 2011; 2011: 373560.
46. Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA. Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 2013; 38: 616-627.
47. Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009; 34: S186-S195.
48. Scharf SH, Liebl C, Binder EB, Schmidt MV, Muller MB. Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One 2011; 6: e16883.
49. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 2003; 88: 277-284.
50. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319-1325.
51. Hubler TR, Scammell JG. Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 2004; 9: 243-252.
52. Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 2010; 15: 574-588.
53. Naughton M, Dinan TG, Scott LV. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease. Handb Clin Neurol 2014; 124C: 69-91.
54. Bear MF, Connors P, Paradiso M. Neuroscience: Exploring The Brain, 3rd edn. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006.